Search hospitals > Washington > Spokane
Providence Sacred Heart Medical Center and Children's Hospital
Claim this profileSpokane, Washington 99204
Global Leader in Tumors
Global Leader in Leukemia
Conducts research for Recurrence
Conducts research for Lymphoma
Conducts research for Cancer
255 reported clinical trials
9 medical researchers
Summary
Providence Sacred Heart Medical Center and Children's Hospital is a medical facility located in Spokane, Washington. This center is recognized for care of Tumors, Leukemia, Recurrence, Lymphoma, Cancer and other specialties. Providence Sacred Heart Medical Center and Children's Hospital is involved with conducting 255 clinical trials across 479 conditions. There are 9 research doctors associated with this hospital, such as Judy L. Felgenhauer, Melanie Bergman, MD, Katherine Tuttle, MD, and Jordan Castle, MD.Area of expertise
1Tumors
Global LeaderStage IV
Stage I
Stage II
2Leukemia
Global LeaderStage II
NTRK1 positive
NTRK positive
Top PIs
Judy L. FelgenhauerProvidence Sacred Heart Medical Center and Children's Hospital7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
67 reported clinical trials
141 drugs studied
Melanie Bergman, MDProvidence Sacred Heart Medical Center and Children's Hospital1 year of reported clinical research
Studies Ovarian Tumors
Studies Fallopian Tube Cancer
6 reported clinical trials
12 drugs studied
Katherine Tuttle, MDProvidence Sacred Heart Medical Center1 year of reported clinical research
Studies Kidney Disease
Studies Diabetes
4 reported clinical trials
6 drugs studied
Jordan Castle, MDProvidence Sacred Heart1 year of reported clinical research
Studies Pulmonary Embolism
Studies Embolism
2 reported clinical trials
3 drugs studied
Clinical Trials running at Providence Sacred Heart Medical Center and Children's Hospital
Brain Tumor
Osteosarcoma
Germ Cell Tumors
Langerhans Cell Histiocytosis
Rhabdomyosarcoma
Non-Hodgkin's Lymphoma
Ovarian Cancer
Ovarian Tumors
Astrocytoma
Neuroblastoma
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Providence Sacred Heart Medical Center and Children's Hospital?
Providence Sacred Heart Medical Center and Children's Hospital is a medical facility located in Spokane, Washington. This center is recognized for care of Tumors, Leukemia, Recurrence, Lymphoma, Cancer and other specialties. Providence Sacred Heart Medical Center and Children's Hospital is involved with conducting 255 clinical trials across 479 conditions. There are 9 research doctors associated with this hospital, such as Judy L. Felgenhauer, Melanie Bergman, MD, Katherine Tuttle, MD, and Jordan Castle, MD.